Vidal M. et al., Gene Expression-based Classifications of Fibroadenomas and Phyllodes tumours of the Breast., [Epub ahead of print]., Molecular Oncology, Jan 31, 2015 ➔

Guinn D. et al., miR-155 expression is associated with chemoimmunotherapy outcome and is modulated by Bruton՚s tyrosine kinase inhibition with Ibrutinib., [Epub ahead of print]., Blood, Jan 27, 2015 ➔

Wang X. et al., Medulloblastoma subgroups remain stable across primary and metastatic compartments., [Epub ahead of print]., Acta Neuropathologica, Jan 21, 2015 ➔

Ramaswamy R. et al., Medulloblastoma subgroup-specific outcomes in irradiated children: who are the true high-risk patients?, [Epub ahead of print]., Neuro-Oncology, Jan 20, 2015 ➔

Spencer D.H. et al., Epigenomic analysis of the HOX gene loci reveals mechanisms that may control canonical expression patterns in AML and normal hematopoietic cells., [Epub ahead of print]., Leukemia, Jan 20, 2015 ➔

Tokes A-M. et al., Expression of proliferation markers Ki67, cyclin A, geminin and aurora-kinase A in primary breast carcinomas and corresponding distant metastases., [Epub ahead of print]., J. Clin. Pathol., Jan 16, 2015 ➔

Wang H. et al., The Osteogenic Niche Promotes Early-Stage Bone Colonization of Disseminated Breast Cancer Cells., [Epub ahead of print]., Cancer Cell, Jan 15, 2015 ➔

Kleppe M. et al., JAK-STAT Pathway Activation in Malignant and Non-Malignant Cells Contributes to MPN Pathogenesis and Therapeutic Response., [Epub ahead of print]., Cancer Discovery, Jan 08, 2015 ➔

Wang K. et al., PEST Domain Mutations in Notch Receptors Comprise an Oncogenic Driver Segment in Triple Negative Breast Cancer Sensitive to a γ-Secretase Inhibitor., [Epub ahead of print]., Clin. Cancer Res., Jan 06, 2015 ➔

Pogue-Geile K.L. et al., Intrinsic Subtypes, PIK3CA Mutation, and the Degree of Benefit From Adjuvant Trastuzumab in the NSABP B-31 Trial., [Epub ahead of print]., J. Clin. Oncol, Jan 05, 2015 ➔

Ananda G. et al., Development and validation of the JAX Cancer Treatment Profileâ„¢ for detection of clinically actionable mutations in solid tumors., [Epub ahead of print]., Experimental and Molecular Pathology, Jan 03, 2015 ➔

Liu S. et al., Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trial., [Epub ahead of print]., Breast Cancer Res. and Treat, Jan 01, 2015 ➔

Andrade V.P. et al., Gene expression profiling of lobular carcinoma in situ reveals candidate precursor genes for invasion., [Epub ahead of print]., Mol. Oncol., Dec 24, 2014 ➔

Park Y-H. et al., A seven-gene signature can predict distant recurrence in patients with triple-negative breast cancers who receive adjuvant chemotherapy following surgery., [Epub ahead of print]., Int. J. Cancer, Dec 24, 2014 ➔

Navari M. et al., Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus., [Epub ahead of time]., Front Microb., Dec 23, 2014 ➔